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Embryonic development is characterized by
dynamic changes in gene expression, yet the role
of chromatin remodeling in these cellular transitions
remains elusive. To address this question, we
profiled the transcriptome and select chromatin
modifications at defined stages during pancreatic
endocrine differentiation of human embryonic stem
cells. We identify removal of Polycomb group
(PcG)-mediated repression on stage-specific genes
as a key mechanism for the induction of develop-
mental regulators. Furthermore, we discover that
silencing of transitory genes during lineage pro-
gression associates with reinstatement of PcG-
dependent repression. Significantly, in vivo- but not
in vitro-differentiated endocrine cells exhibit close
similarity to primary human islets in regard to tran-
scriptome and chromatin structure. We further
demonstrate that endocrine cells produced in vitro
do not fully eliminate PcG-mediated repression on
endocrine-specific genes, probably contributing to
their malfunction. These studies reveal dynamic
chromatin remodeling during developmental lineage
progression and identify possible strategies for
improving cell differentiation in culture.
INTRODUCTION
Embryonic development is a process characterized by rapid
alternations in cellular states, resulting from dynamic changes
in gene expression programs. These changes in gene expres-
sion are initiated by rapidly changing environmental cues, which
affect cellular states by altering chromatin structure and gene
transcription. Increasing evidence suggests that changes in
specific histone modifications, particularly the trimethylation of
histone H3 at lysines 4 and 27, may play a role in coordinating
this highly regulated process. Although H3K4me3 is found at
virtually all active transcriptional start sites (TSS) (Schneider224 Cell Stem Cell 12, 224–237, February 7, 2013 ª2013 Elsevier Incet al., 2004), H3K27me3 enrichment occurs in genes that are
transcriptionally repressed by Polycomb group (PcG) pro-
teins (Cao et al., 2002). Genome-wide studies have shown that
PcG-dependent H3K27 trimethylation is not a universal repres-
sion mechanism, but represses a restricted subset of genes
that typically encode for developmental regulators (Boyer
et al., 2006; Lee et al., 2006). Notably, in undifferentiated embry-
onic stem cells (ESCs), a major portion of developmental genes
that are trimethylated at H3K27 are also enriched in H3K4me3,
creating a bivalent state in which genes are poised for future
activation but remain inactive until the repressive mark is
removed (Bernstein et al., 2006). When ESCs are differentiated
into neurons or fibroblasts, many of these genes resolve their
bivalent state to either H3K27me3 or H3K4me3 (Mikkelsen
et al., 2007). However, critical questions about the significance
of H3K27me3 and H3K4me3 modifications in tissue and
organ development remain unanswered. For example, it is
still unclear whether H3K27me3- and H3K4me3-dependent
changes in chromatin structure are associated with the rapid
cellular transitions of development, whether bivalency, once
resolved, can be reinstated, and whether this mechanism is
relevant during terminal differentiation when cells acquire their
functional properties.
The major limitation for investigating these important ques-
tions has been that transitory lineage intermediates cannot be
isolated in sufficient numbers from embryos to conduct global
chromatin profiling. This limitation can be overcome by recapit-
ulating essential steps of in vivo development in vitro through
directed differentiation of ESCs. Recently, a pancreatic differen-
tiation protocol was developed that sequentially exposes human
ESCs (hESCs) to different signaling factors, thereby moving cells
stepwise through several precursor populations toward the
pancreatic fate (D’Amour et al., 2006; Kroon et al., 2008). First,
hESCs are induced to develop into definitive endoderm (DE),
which is a transitory developmental cell population that gives
rise to intestine, lung, liver, and pancreas. DE is then converted
into cells of the primitive gut tube (GT). Extrinsic cues, known
to be involved in anterior-posterior regionalization of the GT,
are subsequently applied to generate posterior foregut (FG),
followed by the induction of pancreatic endoderm (PE). Upon
implantation into mice, hESC-derived PE from late-stage
cultures differentiates into glucose-responsive, insulin-secreting.
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et al., 2008). Thus, this differentiation protocol enables us to
explore how cells transition through intermediary developmental
stages and to define chromatin-remodelingmechanisms associ-
ated with these transitions.
In contrast to insulin-producing cells produced after engraft-
ment, insulin+ cells generated in vitro are devoid of mature
b cell characteristics. These cells produce little insulin, are not
glucose responsive, and frequently coexpress other pancreatic
hormones (D’Amour et al., 2006). Therefore, although PE gener-
ated by directed differentiation of hESCs is competent to differ-
entiate into functional b cells when implanted into mice, at
present, mature b cells cannot be produced in vitro. What
remains to be determined is how closely the molecular features
of hESC-derived b cells resemble those of their primary human
counterparts and which of these features are insufficiently
induced in vitro.
In this study, we examined changes in chromatin architecture
associated with the rapid cellular transitions of development
by conducting RNA-seq profiling as well as ChIP-seq for
H3K27me3 and H3K4me3 of lineage intermediates during the
stepwise pancreatic differentiation of hESCs in vitro and after
in vivo differentiation into functional endocrine (FE) cells in
mice. We demonstrate that bivalency is highly dynamic and
tightly associated with activation and silencing of developmental
regulators during lineage progression. Moreover, we reveal that
the chromatin of critical b cell genes is aberrantly remodeled
during endocrine cell differentiation in vitro.
RESULTS
Differentiation of Pancreatic Endoderm and Endocrine
Cells from hESCs
To characterize global gene expression and concomitant
changes in chromatin structure during pancreatic lineage
progression, we generated highly pure populations of PE and
intermediate lineage precursors from hESCs in vitro. In addition,
FE cells were produced by further differentiation in mice. To
understand how endocrine differentiation is aberrantly regulated
in vitro, we further analyzed in vitro-differentiated polyhormonal
cells (PH) from late-stage cultures and compared PH to in vivo-
generated FE cells (Figure 1A). To assess purity of each interme-
diate cell population, we examined known markers for each
stage by immunofluorescence staining, flow cytometry, and
qRT-PCR. As expected, the transition from hESCs to the DE
stage was associated with induction of the DE marker SOX17
in 97% of cells along with efficient repression of the pluripotency
marker OCT4 (Figures 1B and 1C; Figures S1A, S1B, and S1H
available online). At the GT stage, SOX17 was drastically
reduced, whereas the GT marker HNF4A became detectable in
99% of cells (Figures 1D, S1B, S1C, and S1H). Progression to
the FG stage was accompanied by the appearance of the
pancreatic progenitor marker PDX1 in 90% of cells (Figures
1E, S1D, and S1H). At the PE stage, additional pancreatic
markers, including SOX9 and NKX6.1, became expressed
(98% SOX9+ and 62% NKX6.1+ cells in PE) (Figures 1F, 1G,
S1E, S1F, and S1H).
Further in vitro differentiation led to induction of the pan-endo-
crine marker chromogranin A (CHGA) and pancreatic hormonesCein almost half of the cells (Figures 1H–1K, S1G, and S1H). As re-
ported (D’Amour et al., 2006; Kroon et al., 2008), endocrine cells
coexpressed multiple hormones (Figure 1H) and were mostly
devoid of the b cell transcription factors (TFs) PDX1 and
NKX6.1 (Figures 1I and 1J). Hormone-negative cells in late-stage
cultures continued to exhibit features of PE, expressing SOX9,
PDX1, and NKX6.1 (Figures 1I–1K).
Implantation of cell aggregates into Scid-Beige mice resulted
in glucose-dependent release of human C-peptide after 16–
18 weeks (Table S1). In grafts retrieved 20 weeks after implanta-
tion, 90%of cells expressedCHGA (Figures S1I and S1J). Similar
to endocrine cells in the adult human pancreas, insulin+ cells in
grafts were devoid of other hormones and strongly expressed
NKX6.1, PDX1, and MAFB, whereas ARX was expressed in
glucagon+ cells (Figures 1L–1N and S1K–S1M). qRT-PCR anal-
ysis of grafts further revealed induction of the mature b cell
marker MAFA (Figure S1H). The acinar marker trypsin was not
detected (Figure S1N) and small clusters of SOX9+ and SPP1+
cells with duct-like morphology (Figure S1O) were rare, confirm-
ing that the majority of engrafted cells adopted endocrine char-
acteristics. Together, our analysis demonstrates that this
protocol allows for highly efficient generation of endocrine cells
by synchronously moving cells through distinct lineage
intermediates.
Identification of Stage-Specific Transcriptional
Programs during Pancreatic Lineage Progression
To identify global changes in gene expression associated with
lineage progression of hESCs to functional endocrine cells, we
performed RNA-seq analysis at six defined stages (ES, DE,
GT, FG, PE, and FE). Bayesian clustering of mRNAs was per-
formed to identify stage-specific signature genes (Figure 2A;
Table S2). As expected, the hESC-specific cluster included
genes involved in maintenance of cellular pluripotency, such as
OCT4 and SOX2 (Figure 2A). Similarly, the DE cluster contained
known regulators of endoderm formation, including EOMES,
MIXL1, and SOX17 (Figures 2A and 2B; Table S2A). Gene
ontology (GO) analysis of DE signature genes revealed the
expected enrichment for genes involved in endoderm develop-
ment, gastrulation, and pattern specification (Figure 2B). More-
over, members of the Wnt signaling pathway were enriched in
the DE cluster, consistent with previously recognized roles for
Wnt in DE formation (Liu et al., 1999).
The PE-specific cluster was enriched for genes involved in
pancreas development and cell fate commitment (Figures 2A
and 2C; Table S2D) and included pancreatic progenitor markers,
such as PDX1, SOX9, HNF6, NKX6.1, and PTF1A. GO term
enrichment for neuron differentiation in the PE cluster is consis-
tent with the previously observed similarity in gene expression
profiles between neuronal and pancreatic precursors (van
Arensbergen et al., 2010).
Genes in the FE-specific cluster were functionally associated
with hormone transport, regulation of hormone levels, andmatu-
rity onset diabetes of the young (MODY) (Figures 2A and 2D;
Table S2E). These GO categories encompassed genes involved
in glycolysis (e.g., GCK, G6PC2), insulin processing (e.g.,
PCSK1, PCSK2, SLC30A8), and insulin secretion (e.g., GLP1R,
KCNJ11, ABCC8, FFAR1, UCN3), revealing that engraftment
induces a complement of genes critical for b cell function. Well Stem Cell 12, 224–237, February 7, 2013 ª2013 Elsevier Inc. 225
Figure 1. Differentiation of hESCs into Pancreatic Endoderm and Endocrine Cells
(A) Schematic of the human embryonic stem cell (hESC)-based differentiation strategy.
(B–N) Immunofluorescence staining of sections from cell aggregates for stage-specific markers shows synchronous and efficient progression of hESCs through
the differentiation steps. Polyhormonal cells (PH) generated in vitro express insulin (INS) together with glucagon (GCG) and somatostatin (SST) (H). CHGA+
(chromogranin A) cells express little PDX1 (I) and INS+ cells are not uniformly NKX6.1+ (J). Retrieved grafts 20 weeks after implantation display INS+ cells negative
for GCG or SST (L) but expressing PDX1 (M) and NKX6.1 (N).
Abbreviations: DE, definitive endoderm; GT, primitive gut tube; FG, posterior foregut; PE, pancreatic endoderm; FE, in vivo-differentiated functional endocrine
cells. Scale bars represent 50 mm. See also Figure S1 and Table S1.
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b cells, including NFIC, the b cell TFs HDAC9 and HOPX (Dorrell
et al., 2011), and HIC1, which exhibits reduced expression in
islets of diabetic rats (Liu et al., 2011). Overall, our transcriptome
analysis shows that key developmental programs are stage
specifically regulated, suggesting that further examination of
the gene signatures could enable discovery of novel lineage
determinants.226 Cell Stem Cell 12, 224–237, February 7, 2013 ª2013 Elsevier IncGenome-wide Profiles of H3K4me3 and H3K27me3
Reveal Dynamic Changes of PcG-Mediated Repression
during Pancreatic Differentiation
In ESCs, genes encoding key lineage-specific regulators are
bivalent, i.e., marked by both H3K4me3 and H3K27me3 (Bern-
stein et al., 2006; Pan et al., 2007). In striking contrast to ESCs,
neural progenitor cells and adult stem cells of the hair follicle
display very few genes in a bivalent state (Lien et al., 2011;.
Figure 2. Stage-Specific mRNA Clusters during Pancreatic Endocrine Differentiation of hESCs
(A) Bayesian clustering of mRNA profiles at the ES, definitive endoderm (DE), primitive gut tube (GT), posterior foregut (FG), pancreatic endoderm (PE), and
functional endocrine (FE) stages identifies stage-specific signature (sig.) genes.
(B–D) Enriched gene ontology categories of DE (B), PE (C), and FE (D) signature genes.
See also Table S2.
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associated with resolution of bivalency to either a fully active or
repressed state. To study bivalency during pancreatic differenti-
ation, we globally mapped H3K4me3 and H3K27me3 modifica-
tions in hESCs, in vivo-differentiated FE cells, and each lineage
intermediate (Table S3). In hESCs, 17% of known transcripts
(3,182/18,822) displayed bivalency at their TSSs and themajority
of these genes (78%) resolved bivalency during hESC differenti-
ation to the FE stage (Figure S2). In addition to loss of bivalency,
we also observed that genes acquired a bivalent state during
the differentiation process (Figure 3A), resulting in a relatively
constant overall number of bivalent genes during progression
to PE. However, this percentage dropped after engraftment,
with only 4.9% (918/18,822) of genes exhibiting bivalency at
the FE stage. In total, the largest number of genes resolved the
bivalent state during terminal endocrine differentiation.
To determine which classes of genes resolve bivalency during
pancreatic differentiation, we performed GO analysis. Genes
bivalent in hESCs that resolve to solely H3K4me3 at any time
point during differentiation (n = 1,717) included many with roles
in endocrine development and function (Figure 3B). ConsistentCewith the large representation of genes involved in endocrine
cell function, a high percentage of these genes (46%) did not
lose the repressive H3K27me3 mark until progression to the FE
stage (Figure 3B). Conversely, genes bivalent in hESCs under-
going loss of the active H3K4me3 mark during progression to
the FE stage (n = 147) were functionally associated with the
development of non-endodermal lineages (Figure 3B). Surpris-
ingly, the majority of these bivalently marked genes (61%) re-
tained H3K4me3 until engraftment (Figure 3B), suggesting that
a large proportion of genes involved in the development of alter-
native lineages remain bivalent at the PE stage. These findings
indicate that PE maintains a high degree of plasticity to adopt
other lineage choices.
Of the promoters resolving or gaining bivalency, the majority
changed their H3K27me3 state, whereas H3K4me3 modifica-
tions were far less dynamically regulated (Figure 3C). This
observation implies a significant role for PcG proteins in chro-
matin remodeling during pancreatic endocrine differentiation.
To glean additional insight into the stage-specific dynamics of
H3K27me3 modifications during differentiation, we employed
hierarchical clustering of genes that exhibit a change inll Stem Cell 12, 224–237, February 7, 2013 ª2013 Elsevier Inc. 227
Figure 3. Genome-wide Changes in H3K4me3 and H3K27me3 Modification Patterns during Pancreatic Endocrine Differentiation
(A) Venn diagram of global H3K27me3 and H3K4me3 patterns showing gain and loss of bivalent domains at each step during progression of hESCs to functional
endocrine (FE) cells. Overall numbers of bivalent domains are stable from the ES to the pancreatic endoderm (PE) stage but decrease significantly at the FE stage.
(B) Gene ontology (GO) analysis of bivalent genes in hESCs resolving to H3K4me3 (left) or H3K27me3 (right) during pancreatic differentiation. GO terms are shown
on the y axis; corrected p values along the x axis. Pie charts (middle) show that bivalent genes in hESCs resolve to either H3K4me3 or H3K27me3 mostly at the
transition to the FE stage.
(C) At each stage, bivalent domains are predominantly lost and gained by modifying methylation of H3K27me3. Total numbers of genes are shown on the y axis.
(D) Hierarchical clustering of normalized tag counts for H3K27me3 during differentiation shows that ES, definitive endoderm (DE), and FE are most distinct, while
primitive gut tube (GT), posterior foregut (FG), and PE exhibit higher similarity. For the clustering, H3K27me3 tags were counted in a region ±2 kb around the
transcriptional start sites and normalized to RPM (reads per million).
See also Figure S2 and Table S3.
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this analysis, the ES, DE, and FE stages surfaced as most
distinct, whereas GT, FG, and PE stages had similar patterns
(Figure 3D). Because of the similarity in chromatin patterns
among the GT, FG, and PE stages, we chose the PE stage as
exemplary for these three stages and focused our subsequent
analysis of stage-specific chromatin modifications on cellular
transitions to the DE, PE, and FE stages.
Transition through the DE Stage Involves Reversal and
Reinstatement of PcG Repression
To understand how chromatin is modified as DE-specific genes
are rapidly induced and silenced during development, we exam-
ined histone profiles of DE signature genes. Consistent with the
notion that lineage-specific developmental regulators display
bivalent modifications in ESCs (Bernstein et al., 2006), many
DE signature genes were bivalent in hESCs (37%of DE signature
genes versus 17% of all genes; p < 1 3 1036, hypergeometric
distribution; Figure S3A). Sequential ChIP-qPCR onDE signature
genes demonstrated a simultaneous presence of H3K4me3 and
H3K27me3 at the ES stage (Figures S4A and S4B), indicating
concurrent enrichment of H3K4me3 and H3K27me3 at the
same locus. Most (54%) DE signature genes bivalent in hESCs
resolved to H3K4me3 at the DE stage, whereas genes solely
marked by H3K4me3 or unmarked in hESCs showed little
change in their histone profile (Figure 4A). Strikingly, the list of
bivalent DE signature genes exhibiting H3K27me3 removal
featured functional association with endoderm formation and
included most known transcriptional regulators of DE specifica-
tion (e.g., GSC, EOMES, MIXL1, SOX17, CER1, and GATA6)
(Figure 4A; Table S4). Reflecting the requirement for Wnt
signaling in DE formation (Liu et al., 1999), the subset of DE
signature genes resolving bivalency was also enriched for Wnt
receptor signaling pathway components (Figure 4A). These
results suggest that removal of PcG-mediated H3K27me3 accu-
mulation at DE regulators could be the predominant mechanism
associated with endoderm induction.
To examine the functional relevance of PcG-dependent chro-
matin remodeling in DE induction, we prevented H3K27me3
removal during the transition from ES to DE by inhibiting Jumanji
C domain-containing protein (JMJD3). JMJD3 antagonizes
PcG-mediated gene silencing by demethylating H3K27me3
(Hong et al., 2007). We utilized two independent shRNAs against
JMJD3, which each led to an 80% reduction in JMJD3 levels
(Figure 4B). Analysis of JMJD3 knockdown cells at the DE stage
revealed significantly reduced expression of the DE signature
genes EOMES, LHX1, NRP2, and SOX17 (Figure 4B). Further-
more, compared to cells transduced with control shRNA,
JMJD3 knockdown cells retained higher H3K27me3 levels at
the promoter regions of these DE signature genes (Figure 4B).
Our findings demonstrate that induction of DE fate determinants
requires removal of H3K27me3 and provides direct evidence
that modulation of PcG-mediated repression is necessary to
initiate endoderm differentiation.
To gain insight into the chromatin modifications associated
with the silencing of DE-specific programs during lineage
progression, we next analyzed histone profiles of DE signature
genes subsequent to the DE stage. We found that a subset of
DE signature genes became bivalent again by progressivelyCeacquiring H3K27me3 at the GT and FG stages (Figures 4C, 4D,
S4A, and S4B). The reacquisition of H3K27me3 after the DE
stage raises the possibility that DE-specific programs are
repressed by PcG-dependent mechanisms. Cluster analysis of
histone methylation patterns revealed three distinct groups of
DE signature genes: genes acquiring the H3K27me3 modifica-
tion either at the GT or FG stage and genes not acquiring this
modification (Figure 4D). Although all three groups of DE genes
exhibited decreased expression at the GT stage, expression of
PcG-modified genes declined earlier than that of genes silenced
in a PcG-independent manner (Figures 4D and S3B). Remark-
ably, TFs involved in DE formation, including the most upstream
DE inducer EOMES (Teo et al., 2011), belonged to the group of
early silenced genes acquiring H3K27me3 at the GT stage
(Figures 4D and S3B), suggesting a role for PcG proteins in the
silencing of DE-specific developmental regulators.
Commitment to the Pancreatic Lineage Entails
Stepwise Derepression of PcG-Silenced Genes
We next examined whether activation of genes during pancre-
atic lineage commitment coincides with the loss of PcG-depen-
dent repression. Analysis of histone profiles of GT, FG, and PE
signature genes (Figure 2A; Tables S2B–S2D) showed that all
stage-specific signature genes exhibit a significantly higher
propensity than total genes to be bivalent in hESCs (17% of all
genes versus 46% of GT [p < 1 3 1017] versus 31% of FG
[p < 1 3 1015] versus 50% of PE [p < 1 3 1031] signature
genes, hypergeometric distribution; Figure 5A). PE signature
genes lost bivalency gradually during progression from the GT
to PE stage (Figure 5B), a finding we confirmed by sequential
ChIP-qPCR (Figures S4A and S4B). However, 26% of PE signa-
ture genes remained bivalent at the PE stage (Figure 5B), which
we reasoned could be because later pancreatic differentiation
factors are just beginning to be expressed. For example, similar
to its expression in the early pancreatic epithelium of mouse
embryos (Henseleit et al., 2005), NKX6.1 was detected in only
a subset of PDX1+ cells at the PE stage (Figures 1F and S1F)
but became uniformly expressed in non-endocrine cells at later
stages (Figure 1J). Therefore, we also analyzed the histone
profiles of PE signature genes in further differentiated pancreatic
endoderm isolated by fluorescence-activated cell sorting
(FACS) from late-stage cultures (Late PE; Figure S5A). As pre-
dicted, almost all PE signature genes (87%) had resolved biva-
lency to H3K4me3 in this late PE population (Figures 5B and
5C). Thus, similar to DE-specific genes, activation of PE-specific
genes was mostly associated with removal of PcG-mediated
repression (Figure 5C). Strikingly, the short list of 104 genes dis-
playing this pattern contained many known TFs necessary for
early pancreas development, encompassing SOX9, PDX1,
PTF1A, HNF6, NKX6.1, and NKX6.2 (Figure 5C; Table S5).
This list also contained several components of the Notch
(HEY1, DLK1, HES4, and JAG1) and Netrin (DCC, UNC5C)
signaling pathways, as well as the TFs MEIS1 and NFKB1 with
still unknown functions in pancreas development. Immunohisto-
chemical analysis of some of these Notch components and TFs
in human fetal pancreas revealed expression in native pancre-
atic progenitors (Figure S5B), suggesting that stage-specific
gene activation and H3K27me3 loss is a strong predictor for
putative regulators of human pancreatic development.ll Stem Cell 12, 224–237, February 7, 2013 ª2013 Elsevier Inc. 229
Figure 4. PcG-Dependent Derepression and Repression Coincides with Activation and Silencing of Definitive Endoderm-Specific Genes
(A) Definitive endoderm (DE) signature genes separated by H3methylation patterns in ESCs (horizontal axis) and how thesemodifications change in DE. Removal
of H3K27me3 on bivalent genes is the predominant change. The table lists gene ontology categories (p < 0.05) of DE signature genes changing from bivalent in ES
to H3K4me3 in DE.
(B) qRT-PCR of JMJD3 shows significant reduction of JMJD3 mRNA levels after lentiviral transduction of hESCs with two different JMJD3 shRNAs (shRNAs#1
and shRNA#2) compared to a scrambled control (ctrl) shRNA (left). qRT-PCR of DE signature genes in control and JMJD3 knockdown cells at the DE stage
(middle). ChIP-qPCR demonstrates increased H3K27me3 occupancy on DE gene promoters after JMJD3 knockdown (right).
(C) Global histonemethylation patterns of DE signature genes at ES, DE, primitive gut tube (GT), and posterior foregut (FG) stages shows removal and subsequent
reacquisition of H3K27me3 on DE signature genes.
(D) Cluster analysis of histone methylation patterns of all DE signature genes resolving from bivalent in ES to H3K4me3 in DE (left). mRNA expression profiles
(RNA-seq) of genes in each cluster shows a correlation between gain of H3K27me3 and extent of gene repression at the GT stage (percent of gene expression in
GT relative to DE).
Data are shown as mean ± SEM from three technical replicates. The statistical values are *p < 0.05; ***p < 0.001. See also Figures S3 and S4 and Table S4.
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genes during lineage progression showed distinct groups of
genes exhibiting early, intermediate, or late reversal of PcG-230 Cell Stem Cell 12, 224–237, February 7, 2013 ª2013 Elsevier Incmediated repression (Figure 5D). Genes with early H3K27me3
loss displayed earlier onset of expression than genes maintain-
ing H3K27me3 until later stages (Figure 5D). Among the genes.
Figure 5. Transcriptional Activation of Pancreatic Developmental Regulators Involves Reversal of PcG-Mediated Repression
(A) Comparison of global H3K4me3 and H3K27me3 patterns of primitive gut tube (GT), posterior foregut (FG), and pancreatic endoderm (PE) signature genes
versus all genes in ES cells reveals a higher propensity of stage-specific than random genes to be bivalent in hESCs.
(B) Analysis of histone profiles of PE signature genes during pancreas differentiation shows that PE signature genes gradually lose bivalency beginning in GT.
(C) PE signature genes separated by H3 methylation patterns in ES cells (horizontal axis) and how these modifications change in PE isolated from late-stage
cultures (late PE). Removal of H3K27me3 on bivalent genes is the predominant change. The table lists gene ontology categories (p < 0.05) of PE signature genes
changing from bivalent in ES to H3K4me3 in late PE.
(D) Cluster analysis of histone methylation patterns of all PE signature genes changing from bivalent in ES to H3K4me3 in FG, PE, or late PE (left). mRNA
expression profiles (RNA-seq) of genes in each cluster shows a temporal correlation between removal of H3K27me3 and gene activation (percent of gene
expression in FG relative to PE).
The statistical values are *p < 0.05; ***p < 0.001. DE, definitive endoderm. See also Figures S4 and S5 and Table S5.
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of NKX6.1, NKX6.2, and PTF1A occurred later. The same order
of gene activation is seen during mouse development (Seymour
and Sander, 2011), indicating that this in vitro differentiation
system mimics normal pancreas specification.CeActivation of Different Classes of Endocrine Genes
Associates with Distinct Patterns of Chromatin
Modification
We next sought to determine which chromatin remodeling
events occur during the in vivo differentiation of PE afterll Stem Cell 12, 224–237, February 7, 2013 ª2013 Elsevier Inc. 231
Figure 6. Induction of Endocrine-Specific Genes Involves Removal of Repressive and Acquisition of Active Histone Modifications
(A) Analysis of global H3K4me3 and H3K27me3 patterns shows that in vivo-differentiated functional endocrine (FE) signature genes are more likely to be bivalent
in hESCs than random genes (left). Cluster analysis of histone methylation patterns reveals that most bivalent FE signature genes maintain bivalency until the
pancreatic endoderm (PE) stage and resolve to H3K4me3 at the FE stage (right).
(B) FE signature genes separated by H3 methylation patterns in PE (horizontal axis) and how these modifications change in FE. Removal of H3K27me3 from the
bivalent state and acquisition of H3K4me3 from the unmodified state are the predominant changes. The table lists gene ontology categories (p < 0.05) of FE
signature genes changing their histone modifications from bivalent in PE to H3K4me3 in FE (red) or from unmodified in PE to H3K4me3 in FE (blue).
Abbreviations: DE, definitive endoderm; GT, primitive gut tube; FG, posterior foregut. See also Figure S4 and Table S6.
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not a unique feature of developmental regulators but that FE
signature genes also displayed a higher propensity to be bivalent
in hESCs than total genes (17% of all genes versus 44% of FE
signature genes [p < 1 3 1057], hypergeometric distribution;232 Cell Stem Cell 12, 224–237, February 7, 2013 ª2013 Elsevier IncFigure 6A). Contrasting findings at earlier stages, only 8.7% of
bivalently modified FE signature genes encoded TFs (compared
to 14%of DE and 22% of PE signature genes bivalently modified
in hESCs). 43% of these genes encoded transmembrane
proteins, including KCNJ11, ABCC8, and GPR120, which are.
Cell Stem Cell
Chromatin Remodeling during Pancreatic Differentiationcritical for b cell function. This was unexpected, because
previous studies suggested that bivalent modifications in hESCs
are predominantly relevant for future activation of TFs involved in
lineage specification (Pan et al., 2007). A stage-wise heatmap of
chromatin modifications revealed that the majority of FE signa-
ture genes bivalently marked at the PE stage were also bivalent
in hESCs (Figure 6A). Sequential ChIP-qPCR verified the pres-
ence of H3K4me3 and H3K27me3 on FE signature genes at all
stages prior to the FE stage (Figures S4A and S4B). Interestingly,
almost all (87%) FE signature genes bivalently marked at the PE
stage resolved to an active H3K4me3 mark after engraftment
(Figure 6B; Table S6A). This subset was enriched for genes
encoding proteins regulating hormone levels (Figure 6B). In
contrast to earlier stages, induction of a substantial number of
FE signature genes coincided with the acquisition of H3K4me3
(18% of DE [Figure 4A] versus 33% of PE [Figure 5C] versus
52% of FE [Figure 6B] signature genes). These H3K4me3
‘‘induced’’ genes mainly comprised genes encoding secreted
proteins, such as INS, GCG, and IAPP (Figures 6A and 6B; Table
S6B). Together, these findings demonstrate that induction of
endocrine-specific genes during pancreas differentiation is
associated with both removal of repressive H3K27me3 and de
novo acquisition of active H3K4me3 modifications.
In Vitro-Generated Endocrine Cells Display Aberrant
Histone Modifications
To examine how closely hESC-derived FE cells resemble their
in vivo counterparts, we directly compared endocrine cell com-
position, transcriptome, and H3K4/K27 trimethylation profiles
of FE to primary human islets (HI). Intracellular flow cytometry
and morphometric analysis for the relative abundance of
different endocrine cell types revealed high similarity between
FE and human islets (40% insulin+ cells in FE versus 55% in
HI; 27% glucagon+ cells in FE versus 38% in HI; and 20%
somatostatin+ cells in FE versus 7% in HI) (Figure S6A; Cabrera
et al., 2006). Notably, the cell type composition of human islets
varies significantly between individuals and the percentage of
insulin+ cells has been reported to range between 28% and
75% (Brissova et al., 2005). Comparison of mRNAs for all genes
or FE signature genes demonstrated highly similar expression
profiles of FE and human islets (Figure S6B). Echoing the findings
at themRNA level, cluster analysis of histone modifications at FE
signature genes (Figure S6C) confirmed close proximity of
hESC-derived in vivo-matured cells to human islets.
Previous studies have shown that insulin+ cells generated from
hESCs in vitro lack important b cell characteristics, such as the
ability to secrete insulin in a glucose-dependent manner
(D’Amour et al., 2006). It has been further demonstrated that
implantation of these cells into mice does not induce their matu-
ration (Kelly et al., 2011). To define the distinguishing features
between in vitro-generated endocrine cells (PH) and FE, we
compared the expression profile of FACS-purified PH (Fig-
ure S5A) with FE retrieved from grafts. Although PH and FE
expressed a significant number of genes at comparable levels
(n = 9,111; p < 1 3 1015, Fisher’s exact test), 1,438 genes dis-
played expression levelsR2-fold higher in FE than PH (FE-high
genes) (Figure 7A; Table S7A). FE-high genes associated with
the GO categories of regulation of hormone secretion, hormone
metabolic process, blood vessel development, and ECM-Cereceptor interaction (Figure 7B). Significantly, FE-high genes
were found similarly expressed in human islets (Figure 7C).
Comparison of H3K4me3 and H3K27me3 profiles of FE-high
genes in PE, PH, FE, and primary islets further revealed high
similarity between PH and PE, but not between PH and FE or
islets (Figure 7D), suggesting that chromatin architecture is inap-
propriately remodeled during in vitro differentiation.
To determine whether aberrant chromatin modifications are
associated with insufficient induction of b cell genes in vitro,
we further analyzed the specific changes in histone modifica-
tions during the transition from PE to either the FE or PH stage.
As expected, 82% (368/451) of FE-high genes with bivalent
marks at the PE stage lost the repressive H3K27me3 mark after
engraftment (Figure 7E). Strikingly, 48% (175/368) of these
genes aberrantly retained H3K27me3 in PH (Figure 7E; Table
S7B). Another group of FE-high genes was marked solely by
H3K27me3 at the PE stage (n = 36). Although 75% of these
genes lost the repressive H3K27me3 mark during in vivo differ-
entiation to FE, only 44% underwent the same change during
in vitro differentiation (Figure 7E; Table S7B). Moreover, 50%
of FE-high genes with neither H3K4me3 nor K3K27me3 modifi-
cations in PE (n = 496) acquired the active H3K4me3 mark after
engraftment, but only 5.8% gained H3K4me3 in vitro (Figure 7E;
Table S7C). Together, these findings suggest that the insufficient
induction of endocrine genes during in vitro differentiation is
associated with inadequate changes in H3K27me3 and
H3K4me3 modification patterns.
GO analysis of FE-high genes remaining inappropriately PcG
repressed (n = 186) or failing to acquire H3K4me3 (n = 222) in
PH revealed enrichment for genes with functions related to
hormone activity, cell proliferation, and ion homeostasis (Fig-
ure 7E). In addition to insulin, the list of genes showing aberrant
histone modifications in PH included GLP1R, FFAR1, and UCN3
(Figure 7E), which are required for glucose-stimulated insulin
secretion (Itoh et al., 2003; Li et al., 2007; Preitner et al., 2004).
Given that in vitro-generated insulin-expressing cells exhibit
insufficient insulin production and lack glucose-regulated secre-
tion (D’Amour et al., 2006), our data suggest that inappropriate
chromatin remodeling during in vitro differentiation could
contribute to the malfunction of these cells.
DISCUSSION
The Role of PcG-Dependent Repression and
Derepression Mechanisms during Progression of
Pluripotent Cells toward the Pancreatic Endocrine
Lineage
Because of the limited accessibility and quantity of transitory
embryonic cell populations, bivalent domains have been studied
only in select cellular contexts (Bernstein et al., 2006; Lien et al.,
2011; Mikkelsen et al., 2007; Pan et al., 2007). Therefore, the
coexistence of repressive H3K27me3 and activating H3K4me3
histone marks at the same locus has remained controversial,
because it is not easy to determine whether this dual histone
mark represents different cells within a heterogeneous tissue.
In this study, we experimentally demonstrate the concurrent
enrichment of H3K4me3 and H3K27me3 at the same locus
and show that at each step of lineage progression, critical devel-
opmental regulators resolve their bivalent state concomitantll Stem Cell 12, 224–237, February 7, 2013 ª2013 Elsevier Inc. 233
Figure 7. Aberrant Histone Modifications of Genes Inefficiently Induced during In Vitro Endocrine Differentiation
(A) Venn diagram comparing genes expressed in in vitro-generated polyhormonal cells (PH) and in vivo-differentiated functional endocrine (FE) cells reveals
1,438 genes with higher expression in FE (FE-high genes). Genes with <2-fold difference in expression value between PH and FE are considered common to
both cell types.
(B) Gene ontology (GO) analysis of genes with higher expression in FE shows enrichment for GO terms associated with endocrine cell function. GO terms
are shown on the y axis; p values along the x axis.
(C) Hierarchal clustering of mRNA levels for FE-high genes in pancreatic endoderm (PE), PH, FE, and human islet donor (HI1 and HI2) samples.
(D) Hierarchal clustering of histone modification levels for FE-high genes in PE, PH, FE, and human islet samples.
(E) Genes highly expressed in FE separated by H3 methylation patterns in PE (horizontal axis) and how these modifications change in FE and PH. A large number
of genes losing H3K27me3 or acquiring H3K4me3 during the PE to FE transition are not appropriately modified during in vitro differentiation. The table lists gene
ontology categories (p < 0.05) of FE-high genes inappropriately retaining H3K27me3 (red) or failing to acquire H3K4me3 during in vitro compared to in vivo
differentiation.
See also Figure S6 and Table S7.
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bivalent domains and lends clear evidence to their biological
relevance. For example, the group of genes featuring bivalency
in hESCs, loss of H3K27me3, and induction of expression at
the DE stage included most of the known cell fate determinants
for DE formation. Likewise, the major regulators of early
pancreas development followed this pattern during PE forma-
tion. Therefore, removal of PcG-mediated repression appears
to be the preferred induction mechanism for genes involved in
developmental lineage progression. Consequently, genes with
still unknown functions exhibiting stage-specific induction and
loss of bivalency are likely to have developmental roles. Particu-
larly interesting was the presence of several components of the
Notch and Netrin signaling pathways in this short list of genes
associated with pancreatic lineage commitment. Although
Notch signaling has a well-established role in terminal differenti-
ation of pancreatic cells (Apelqvist et al., 1999), it is still unknown
whether Notch or Netrin signaling is required for cell fate commit-
ment to the pancreatic lineage. Notably, Netrins are expressed in
embryonic pancreatic endothelial cells (Yebra et al., 2011) and
endothelial cues are required for early pancreas development
(Lammert et al., 2001), suggesting that Netrins could relay
signals between the endothelium and foregut progenitors during
pancreatic fate induction.
We found that critical transcriptional regulators of DE forma-
tion first exhibited removal of PcG repression at DE entry and
then quickly reacquired PcG repression upon exiting the DE
stage. Based on the observation that SMAD2/3 recruits the
H3K27 demethylase JMJD3 to EOMES, SOX17, and GSC (Kim
et al., 2011; Teo et al., 2011), it has been suggested that
endodermal gene activation depends on active removal of
H3K27me3 repressive marks. By directly demonstrating that
JMJD3-mediated removal of H3K27me3 is necessary for the
activation of DE-specific genes, our study establishes a causa-
tive role for H3K27me3 modification in gene regulation. More-
over, we show that during lineage progression, key regulators
of DE formation quickly regain PcG-dependent H3K27me3
modifications, resulting in rapid loss of gene expression upon ex-
iting the DE stage. Many of the genes regaining the H3K27me3
repressive mark at DE exit (i.e.,ROR2 and SOX17) need to be re-
activated when DE differentiates into other DE-derived tissues
and organs, such as the lung, intestine, or gallbladder (Spence
et al., 2009; Yamada et al., 2010). Thus, PcG-mediated gene
repression appears to provide a particularly rapid and flexible
mode of gene regulation during differentiation and therefore
specifically associates with genes important for transitory
lineage intermediates. This mechanism might also be relevant
for similar gene regulation during the development of other
germ layers because it allows cells to maintain the molecular
flexibility of quickly reinitiating expression at a later time point.
Our data further revealed that resolving bivalency to an active
H3K4me3 state also associated with the induction of genes
important for endocrine cell function during terminal differentia-
tion. This contrasts findings in neuronal development, during
which the majority of initially bivalently modified genes resolve
bivalency in neuronal progenitors and not during terminal
differentiation into neurons (Mikkelsen et al., 2007). Thus, our
study reveals a role for bivalent domains after early lineage
commitment and demonstrates differences in how chromatinCearchitecture is remodeled during development of different
tissues.
Aberrant Chromatin Modifications during Endocrine
Differentiation In Vitro
A major limitation of significant health relevance is that culture
conditions supporting efficient production of b cells capable of
reversing diabetes remain to be identified. At present, effects
of a large number of different culture conditions on b cell matu-
ration are difficult to examine in vitro, because analysis tools
are largely limited to functional studies of glucose-dependent
insulin secretion. Our global gene expression analysis shows
that engraftment of PE into mice induces a gene expression
program with remarkable similarity to primary human islets.
The list of genes that distinguishes in vivo- from in vitro-differen-
tiated cells will be a valuablemolecular read out for assessing the
extent to which modified culture conditions can produce cells
in vitro with closer similarity to functional b cells.
We observed that the insufficient induction of endocrine genes
in vitro was associated with aberrant histone modification
patterns during terminal differentiation into endocrine cells.
This aberrant pattern was seen on important b cell genes, such
as insulin, the recently identified b cell maturation marker
UCN3 (Blum et al., 2012), and the FFAR1 and GLP1 receptors,
which modulate glucose-dependent insulin secretion (Itoh
et al., 2003; Preitner et al., 2004). Thus, incorrect chromatin re-
modeling during terminal endocrine differentiation in vitro might
be an important factor that contributes to the malfunction of
these cells. Notably, TFs known to regulate functional properties
of b cells, such as the MODY3 gene HNF1A (Horikawa et al.,
1997) and the type 2 diabetes-associated genes TCF7 and
HHEX (Sladek et al., 2007), are also insufficiently induced during
in vitro differentiation. It is tempting to speculate that the
absence of these TFs could be responsible for insufficient activa-
tion and inappropriate chromatin remodeling of b cell genes,
such as insulin, UCN3, FFAR1, and GLP1R during in vitro differ-
entiation. Supporting this idea, HNF1A has been shown to recruit
histone-modifying complexes that lead to site-specific H3K4
methylation while preventing H3K27 trimethylation (Luco et al.,
2008). Future experiments will determine whether manipulations
of these TFs or chromatin-modifying enzymes could help
produce fully differentiated b cells in vitro. Protocols to generate
such cells will have important applications for cell replacement
therapies and research into the pathogenesis of diabetes.
EXPERIMENTAL PROCEDURES
hESC Culture and Human Tissue and Animal Experiments
CyT49 hESCs were maintained and differentiated as previously described
(Kroon et al., 2008; Schulz et al., 2012). hESC research was approved by the
University of California San Diego Institutional Review Board and Embryonic
Stem Cell Research Oversight Committee. For further details, see Supple-
mental Experimental Procedures. The use of human islets from deceased
organ donors was approved by the University of Pennsylvania Institutional
Review Board. Animal experiments were performed at Absorption Systems
(San Diego, CA) and were approved by their Institutional Animal Care and
Use Committee.
ChIP-seq Sample Preparation and Analysis
Chromatin immunoprecipitations were performed as previously described
(Bhandare et al., 2010). In brief, samples were crosslinked in 1.1%ll Stem Cell 12, 224–237, February 7, 2013 ª2013 Elsevier Inc. 235
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with 0.125 M glycine/PBS. Samples were subsequently washed twice with
PBS and then lysed in 1% SDS. For sonication, lysates were sonicated with
a Bioruptor Sonicator (Diagenode) three times for 5 min each with a 30 s
on-and-off cycle, resulting in 200–500 bp chromatin fragments. Sheared chro-
matin was incubated overnight at 4C with 50 ml of Dynabeads sheep anti-
rabbit IgG (Life Technologies), preincubated with 5 mg rabbit anti-H3K4me3
(Millipore, 04-745) or rabbit anti-H3K27me3 (Millipore, 07-499) antibodies.
Immunoprecipitated complexes were further eluted, reverse crosslinked,
and subjected to library preparation. For aggregated hESC-derived and
FACS-sorted samples, a total of 2–5 3 106 cells were used for each ChIP-
seq run. For transplanted samples, three grafts from each transplantation
cohort were pooled and used for both ChIP-seq and RNA-seq analysis.
ChIP-seq libraries were prepared as per Illumina’s instructions (http://www.
illumina.com). For input library preparation, 10 ng of input DNA from each
sample was used. After adaptor ligation, DNA fragments were size-fraction-
ated by gel electrophoresis and excised at 200 ± 25 bp. After gel purification,
DNA fragmentswere amplifiedwith 18PCRcycles and purifiedwith aMiniElute
PCR Purification kit (QIAGEN). 10 nM purified DNAwas loaded on the flow cell,
and sequencing was performed on an Illumina/Solexa Genome Analyzer II in
accordance with the manufacturer’s protocols.
The Homer package was used to define regions enriched for H3K4me3
and H3K27me3 binding (Heinz et al., 2010), overlapping gene TSS regions
defined by RefSeq. See Supplemental Experimental Procedures for additional
details.
RNA-seq Sample Preparation and Analysis
Strand-specific RNA-seq libraries were prepared as previously described
(Parkhomchuk et al., 2009), with minor modifications. In brief, cells were lysed
in Trizol (Life Technologies) for extraction of total RNA. Residual contami-
nating genomic DNA was removed with the Turbo DNase kit (Ambion).
mRNA was isolated from 2 mg of DNA-free total RNA with the Dynabeads
mRNA Purification kit (Life Technologies). After purification, mRNA was
primed with olig(dT)s and random hexamers and reverse-transcribed to
first-strand cDNA. Residual dNTPs were removed with Illustra MicroSpin
G-25 columns (GE Healthcare). In the second-strand synthesis reaction,
dUTPs were used instead of dTTPs. The double-strand cDNAwas fragmented
with a Bioruptor Sonicator for 60 cycles of 30 s on and off. After end-repair and
adenine base addition, the cleaved double-strand cDNA fragments were
ligated to Pair-end Adaptor Oligo Mix (Illumina) and size-fractionated on
a 2% agarose gel (Sigma). cDNA fragments of 200 ± 25 bp were recovered
and incubated with uracil-N-glycosylase (UNG) to digest the second-strand
cDNA. Purified single-strand cDNA was then used as template for 15 cycles
of amplification with pair-end PCR primers (Illumina). The amplified products
were separated on a 2% agarose gel and a band between 225 and 275 bp
excised.
For each sample, sequence reads were aligned to the transcriptome via
RUM, and a ‘‘Feature Quantification’’ (FQ) value was computed for each
RefSeq mRNA transcript, where each FQ value = the number of reads overlap-
ping each transcript permillion reads sequenced, per kb of transcript length. In
accordance with recommendations from ENCODE and the BCBC, these
experiments were performed on two independent biological replicates. The
FQ values for each pair of sample replicates showed high correlation and
were therefore averaged together before subsequent analysis. For each
unique gene symbol, a single representative transcript was chosen, having
the highest single FQ value for any one sample (see Supplemental Experi-
mental Procedures).
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